Home Featured

Featured

Random

Red Light Holland to Partner with Leading Fresh and Dried Mushroom Producers on East Coast Facility

Psychedelic Bulletin #117 – A Deep Dive Into Psilocybin for Alochol Use Disorder; Former MindMed CMO Alleges IP Was Syphoned off to Competitor; ARK...

PT236 – Dr. Carl Hart – Drugs: Honesty, Responsibility, and Logic

Lusaris Therapeutics Launches with $60 Million Series A Financing to Redefine the Treatment of Severe Neuropsychiatric and Neurological Disorders

PT302 – Dr. Adele Lafrance – Vital Psychedelic Conversations

Lobe Sciences Ltd. Strengthens Its Balance Sheet

COMPASS Pathways Announces Fourth Quarter and Year-End 2022 Financial Results ...

Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100

MindMed Joins Clinical Trials Transformation Initiative

Cybin Announces Launch of EMBARK Psychedelic Facilitator Training Program

Numinus Develops Mushroom Tea for Use in Psychedelic Research

Webinar – Unraveling the Top 3 Psychedelic Neuroscience Myths

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel

UK Set to Become Hub of Psychedelic Research, as British Startup...

Cybin Progresses Two Psychedelic Investigational New Drug (“IND”) Candidates and Announces...

12 3...202 Page 1 of 202

Dispatch from ECNP New Frontiers: Psychedelics (Psychedelic Bulletin #134)

Psychedelics Weekly – More Trouble For Field Trip Health, Ketamine Wellness...

atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.